Sponsors

RECENT NEWS

Genetic link between weight-loss jabs and pancreatitis investigated

The pioneering Yellow Card Biobank, launched by the Medicines and Healthcare products Regulatory Agency (MHRA) and Genomics England, is investigating whether the risk of acute pancreatitis from GLP-1 injections for weight loss and type 2 diabetes may be influenced by a person’s genes.

Diatron launches new flagship clinical chemistry system

Diatron has launched its new clinical chemistry analyser, the P780. The system is designed to provide outstanding performance and maximum efficiency, without compromising affordability, to meet the growing demands of modern laboratories.

New research reveals enzyme's influence over cancer cells

Cell biologists have made a significant advance, uncovering the key role of an enzyme in determining the physical structure and behaviour of cancer cells, including how they spread.

IBMS welcomes Government Industrial Strategy

The Institute of Biomedical Science (IBMS) has welcomed the publication of the new Industrial Strategy and its focus on life sciences.

Updated Business Plan published by MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) has published its Business Plan for 2025–26, the final year covered by its 2023-2026 Corporate Plan.

PathAI DP platform receives FDA clearance for primary diagnosis

Digital pathology and AI firm PathAI has announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for AISight Dx - its digital pathology image management system - for use in primary diagnosis in clinical settings.

EVIDENT launches new CE-marked whole-slide scanner

Evident has announced the launch of the SLIDEVIEW DX VS200 universal whole-slide imaging scanner, a CE-marked device under the EU IVDR for use in clinical diagnostics in Europe.

MHRA to lead safe use of AI in global healthcare

The MHRA will help shape international rules for AI in healthcare – speeding up access to safe, effective technologies into the NHS and worldwide, after the UK became one of the first countries in the world to join a new global network of health regulators.

LabMed welcomes new President

Clinical scientist Ian Godber stepped into the role of President of the Association for Laboratory Medicine (LabMed), at LabMedUK25 in Manchester on 11 June 2025, officially succeeding Kath Hayden. The Association also unveiled a new five-year strategy at the event.

PathPresenter receives FDA clearance for digital pathology Clinical Viewer

PathPresenter, an image management system and workflow platform for digital pathology, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the PathPresenter Clinical Viewer for the purpose of primary diagnosis.

FMS brings UV Medico decontamination solutions to the UK

Facility Monitoring Systems (FMS), part of the Trescal family and a trusted provider of contamination control solutions, has formed a strategic partnership in the UK with Denmark-based UV Medico A/S. The agreement sees FMS support and supply UV Medico’s entire range of safe and efficient Far-UVC light-emitting devices to industries across the country.

Acquisition strengthens bioMérieux’s NGS capabilities

Diagnostics firm bioMérieux has announced an agreement to acquire the assets of Day Zero Diagnostics, a US-based infectious disease diagnostics company using genome sequencing and machine learning to combat the rise of antibiotic-resistant infections.

Puerto Rico trial for stroke blood test

Upfront Diagnostics has launched a pioneering clinical study in Puerto Rico to evaluate its novel stroke blood test, LVOne.

Study shows wastewater surveillance accurately predicts COVID-19 infections

A new study from a University of Minnesota research team has demonstrated that measuring SARS-CoV-2 in wastewater continues to accurately predict COVID-19 infections in a community.

Lower cost genetic testing offers a cost-effective tool for early prostate cancer detection

A new research paper further underscores the relevance of RFLP-based genotyping as an affordable substitute for next-generation sequencing for early prostate cancer detection, in light of limited accessibility in many resource-limited settings.

Genomics England Research Summit

Genomics England’s 2025 Research Summit recently welcomed a captivated audience to hear about the latest research and technological innovations from Genomics England, participants, its esteemed research community and members of the wider genomic research and healthcare community.

Aiforia releases CE-IVD-marked clinical AI solution for breast cancer diagnostics

Aiforia Technologies has launched a new CE-IVD marked clinical AI solution for breast cancer grading.

MHRA expands ‘Airlock’ testing programme to support AI innovations

The Medicines and Healthcare products Regulatory Agency (MHRA) has opened a second round of applications to its AI Airlock programme following a successful pilot phase.

MHRA looks to become global leader

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has launched its refreshed strategic direction, with new CEO Lawrence Tallon saying the agency will focus on safety, accelerated access and innovation as it looks to become a global leader in risk-proportionate regulation.

CAP to launch AI pathology ‘discovery hub’

The College of American Pathologists (CAP) is to launch a new virtual artificial intelligence (AI) platform to give pathologists experience with digital technology.

Latest Issues